Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · CHIEF EXECUTIVE OFFICER | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 806,111 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 5,361 · Balance 806,111 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1 F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,348 | $36.76 | $49,552.48 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,576 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $37.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2023 Filed May 18, 2023 23:18 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,568 | $38.24 | $59,960.32 |
DisclosureSEC source: 0001628280-23-018931 · wf-form4a_168445186741302.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 69,750 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: The amount reported in Column 5 of Table I reflects the number of shares of common stock indirectly held by the Reporting Person as of the date of the original Form 4 filing on May 10, 2023. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 09, 2023 Filed May 18, 2023 23:18 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,095 | $37.61 | $229,232.95 |
DisclosureSEC source: 0001628280-23-018931 · wf-form4a_168445186741302.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 71,318 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $38.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,932 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,040,164 Underlying: Common Stock · 22,932 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,733 | $35.09 | $201,170.97 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 77,750 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 22,932 | $35.09 | $804,683.88 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 22,932 | $3.95 | $90,581.40 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,857 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,063,096 Underlying: Common Stock · 1,857 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 464 | $35.00 | $16,240.00 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 83,483 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,857 | $35.00 | $64,995.00 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,857 | $3.95 | $7,335.15 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,370 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,064,953 Underlying: Common Stock · 8,370 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,093 | $35.01 | $73,275.93 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 83,947 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,370 | $35.01 | $293,033.70 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:59 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 8,370 | $3.95 | $33,061.50 |
DisclosureSEC source: 0001628280-23-012989 · wf-form4_168245637932511.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 7,977 | $32.12 | $256,221.24 |
DisclosureSEC source: 0001628280-23-010906 · wf-form4_168073362666449.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,041 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-007542 · wf-form4_167848380314416.xml · derivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,073,323 Underlying: Common Stock · 1,041 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 260 | $35.00 | $9,100.00 |
DisclosureSEC source: 0001628280-23-007542 · wf-form4_167848380314416.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 86,040 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,041 | $35.00 | $36,435.00 |
DisclosureSEC source: 0001628280-23-007542 · wf-form4_167848380314416.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,041 | $3.95 | $4,111.95 |
DisclosureSEC source: 0001628280-23-007542 · wf-form4_167848380314416.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,151 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074,364 Underlying: Common Stock · 22,151 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,538 | $35.29 | $195,436.02 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 86,300 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 22,151 | $35.29 | $781,708.79 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 22,151 | $3.95 | $87,496.45 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,515 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,000 | $35.81 | $286,480.00 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 91,838 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.41 to $36.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,000 | $35.81 | $1,145,920.00 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.41 to $36.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-007014 · wf-form4_167831172532298.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · derivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,515 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,000 | $36.26 | $290,080.00 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 99,838 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.79 to $36.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,000 | $36.25 | $1,160,000.00 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.79 to $36.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,160,515 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 64 | $37.79 | $2,418.56 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 107,838 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to 37.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,496 | $36.67 | $54,858.32 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 107,902 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $37.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,440 | $35.97 | $231,646.80 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 109,398 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.49 to $36.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 254 | $37.79 | $9,598.66 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to 37.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,988 | $36.67 | $219,579.96 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,155 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $37.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 25,758 | $35.97 | $926,515.26 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,143 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.49 to $36.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-006541 · wf-form4_167813861299398.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · derivative · entry 16 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,192,515 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 340 | $38.46 | $13,076.40 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 14 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 115,838 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.43 to $38.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,000 | $37.95 | $189,750.00 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 13 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 116,178 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.42 to $38.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,660 | $36.86 | $98,047.60 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 121,178 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,360 | $38.46 | $52,305.60 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.43 to $38.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,000 | $37.95 | $759,000.00 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,261 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.42 to $38.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,640 | $36.86 | $392,190.40 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,261 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · derivative · entry 15 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,224,515 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.